Further novel forms of interfering RNA molecules

Details for Australian Patent Application No. 2008207337 (hide)

Owner Atugen AG

Inventors Kaufmann, Joerg; Giese, Klaus; Klippel-Giese, Anke

Agent Pizzeys

Pub. Number AU-A-2008207337

Parent 2003260370

Filing date 15 August 2008

Wipo publication date 4 September 2008

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

4 September 2008 Application Open to Public Inspection

  Published as AU-A-2008207337

4 September 2008 Complete Application Filed

4 February 2010 Amendment Made

  The nature of the amendment is: Amend the applicant name from Atugen AG to Silence Therapeutics AG

20 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008207338-Treatment of chronic joint inflammation using an antibody against the CD3 antigen complex

2008207336-Information system for contact center users